Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth

1 month ago 23

Catherine Talavera

Wed, April 22, 2026 astatine 9:27 AM CDT 2 min read

Vir Biotechnology, Inc. (NASDAQ:VIR) is 1 of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock’s terms grew 91.62% from a twelvemonth ago, portion it registered an 80.98% summation year-to-date. On April 16, Vir Biotechnology announced the closing of its planetary collaboration and licensing statement with Astellas pursuing the expiration of the waiting play nether the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The collaboration aims to accelerate the improvement of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeted, PRO-XTEN dual-masked T-cell engager (TCE) for the attraction of metastatic prostate cancer.

Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings

Upon closing of the partnership, Vir Biotechnology said it received a $240 cardinal upfront outgo and a $75 cardinal equity concern astatine a terms of $10.36 per share. The institution volition besides person a near-term $20 cardinal milestone payment, volition divided U.S. profit/loss arsenic with Astellas (50/50), and is eligible to person up to an further $1.37 cardinal successful development, regulatory, and income milestones, on with tiered, double-digit royalties connected ex-U.S. nett sales. Under the presumption of Vir Biotechnology’s licensing statement with Sanofi, a information of definite collaboration proceeds volition beryllium shared with the latter.

Vir Biotechnology, Inc.(NASDAQ:VIR) is simply a clinical-stage biopharmaceutical institution focused connected powering the immune strategy to alteration lives by discovering and processing medicines for superior infectious diseases and cancer. Its objective signifier portfolio includes programs for chronic hepatitis delta and aggregate PRO-XTEN dual-masked T-cell engagers crossed validated targets successful coagulated tumor indications.

While we admit the imaginable of VIR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Data Center Stocks to Buy for the Long Term and 8 Must-Buy Small Cap Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article